Methods of treating neurological conditions by neuromodulation of interhemispheric fibers

• US 7,697,991 B2
• Filed: 05/04/2005
• Issued: 04/13/2010
• Est. Priority Date: 05/04/2004
• Status: Active Grant

• Current Assignee: Cleveland Clinic Foundation
• Original Assignee: Cleveland Clinic Foundation
• Inventors: Machado, Andre, Rezai, Ali R.
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): Gedeon; Brian T
• Application Number:
  US11/121,056
• Publication Number:
  US 20050283201A1
• Time in Patent Office: 1,805 Days
• Field of Search: 607/45, 607/3
• US Class Current: 607/45
• CPC Class Codes: A61N 1/36067 Movement disorders, e.g. tremor or Parkinson disease stimulating motor muscle A61N1/36003
• CPC Class Codes: A61N 1/36075 Headache or migraine
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/36103 Neuro-rehabilitation; Repair or reorganisation of neural tissue, e.g. after stroke

Abstract

Methods of treating various medical conditions by neuromodulation of a target site of interhemispheric fibers. Such medical conditions include unilateral motor deficits, movement disorders, psychiatric disorders, speech or cognitive deficits associated with hemispheric lesions, visual deficits associated with hemispheric lesions, hereditary/genetic disorders, congenital malformations, infection disease, degenerative disorder, autoimmune disorders, and metabolic disorders. A method of providing recovery and rehabilitation from states of reduced consciousness by neuromodulating a target site of interhemispheric fibers is also provided.

Claims

1. A method for rehabilitating a patient comprising:

identifying a patient having a chronic and permanent neurological condition resulting from a lesion to a cerebral hemisphere;

placing a therapy delivery device on a target site of interhemispheric fibers of the patient;

selecting stimulation parameters for a therapy signal; and

activating the therapy delivery device to deliver the therapy signal to the target site to treat the patient'"'"'s condition.

2. The method of claim 1, wherein the neurological condition is at least one of a language deficit, a visual deficit, a motor deficit, a cognitive deficit, a learning deficit, and a sensory deficit.

3. The method of claim 2, wherein the motor deficit is at least one of lack of coordination, paralysis, hemiparesis, and paresis.

4. The method of claim 2, wherein the visual deficit is blindness.

5. The method of claim 2, wherein the cognitive deficit is apraxia.

6. The method of claim 2, wherein the sensory deficit is hypoesthesia.

7. The method of claim 2, wherein the language deficit is aphasia.

8. The method of claim 1, wherein the neurological condition is at least one of a psychiatric disorder and a movement disorder.

9. The method of claim 8, wherein the psychiatric disorder is at least one of depression and schizophrenia.

10. The method of claim 8, wherein the movement disorder is at least one of tremor and spasticity.

11. The method of claim 1, wherein the neurological condition is a pain syndrome.

12. The method of claim 11, wherein the pain syndrome is at least one of chronic pain, neuropathic pain, complex regional pain syndrome I and II, headache, and atypical facial pain.

13. The method of claim 12, wherein the headache is at least one of a migraine headache or a cluster headache.

14. The method of claim 12, wherein the neuropathic pain is at least one of chronic neuropathic pain and neuropathic facial pain.

15. The method of claim 1, wherein the neurological condition is stroke.

16. The method of claim 1, wherein the neurological condition is autism.

17. The method of claim 1, wherein the neurological condition is at least one of a state of reduced consciousness and a minimally conscious state.

18. The method of claim 1, wherein the neurological condition is a deficit in planning function.

19. The method of claim 1, wherein the neurological condition is a deficit in integration of function.

20. The method of claim 1, wherein the target site is the corpus callosum.

21. The method of claim 1, wherein the therapy signal comprises at least one of an electrical signal, a chemical signal or both the electrical signal and the chemical signal.

22. The method of claim 1, wherein the therapy signal is a chemical signal.

23. The method of claim 1, wherein the therapy signal is both an electrical signal and a chemical signal.

24. A method for rehabilitating a patient comprising:

identifying a patient having a chronic and permanent neurological condition resulting from a lesion to a cerebral hemisphere;

placing a therapy delivery device on a target site of interhemispheric fibers of the patient;

sensing a bodily activity of the patient associated with the condition and generating a sensor signal;

in response to the sensor signal, selecting or re-adjusting stimulation parameters for a therapy signal; and

activating the therapy delivery device to initiate application of the therapy signal to the target site of the patient to treat the condition.